STAT3 and cardiomyopathy: In summary, although more distinct gp130/STAT3-dependent mechanisms still remain elusive, based on our studies, the cardioprotective effects of SPRC are possibly accounted for gp130/STAT3-mediated protection against Dox-induced cardiomyopathy (Figure 8).